Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

CD28-Costimulation Provided through a CD19-Specific Chimeric Immunoreceptor Enhances In Vivo Persistence and Anti-Tumor Efficacy of Adoptively Transferred T Cells.

Claudia M. Kowolik, PhD, Sergio Gonzalez, BS, Simon Olivares, BS, Michael Jensen, MD, Laurence J.N. Cooper, MD, PhD

Blood (2005) 106 (11): 1278.

https://doi.org/10.1182/blood.V106.11.1278.1278

Published: 2005

Journal Articles

Artificial Antigen Presenting Cell Can Be Used To Propagate Genetically Modified CD19-Specific T Cells through Chimeric Antigen Receptor.

Tontanai Numbenjapon, MD, Lisa Marie A. Serrano, BS, Simon Olivares, BS, Wen-Chung Chang, BS, Harjeet Singh, PhD, Claudia M. Kowolik, PhD, Sergio Gonzalez, BS, Nancy Gonzalez, BS, Laurence J.N. Cooper, MD/PhD

Blood (2005) 106 (11): 1295.

https://doi.org/10.1182/blood.V106.11.1295.1295

Published: 2005

Journal Articles

Enhanced antilymphoma efficacy of CD19-redirected influenza MP1–specific CTLs by cotransfer of T cells modified to present influenza MP1

Laurence J. N. Cooper, Zaid Al-Kadhimi, Lisa Marie Serrano, Timothy Pfeiffer, Simon Olivares, Adrian Castro, Wen-Chung Chang, Sergio Gonzalez, David Smith, Stephen J. Forman, Michael C. Jensen

Blood (2005) 105 (4): 1622–1631.

https://doi.org/10.1182/blood-2004-03-1208

Published: 2005

Journal Articles

Cord Blood-Derived T Cells Can Be Genetically Engineered to Be B-Lineage All-Specific: Towards Adoptive Immunotherapy after Umbilical Cord Blood Transplantation.

Laurence J.N. Cooper, MD, PhD, Lisa Marie Serrano, BA, Zaid Al-Kadhimi, MD, Simon Olivares, BS, Sergio Gonzalez, BA, Timothy Pfeiffer, BS, Joseph Rosenthal, MD, Steven J. Forman, MD, Michael C. Jensen, MD

Blood (2004) 104 (11): 48.

https://doi.org/10.1182/blood.V104.11.48.48

Published: 2004

Journal Articles

T Cells Genetically Modified to Be CD19-Specific with Improved Potential for Trafficking and Activation.

Zaid Al-Kadhimi, MD, Lisa Marie Serrano, BA, Simon Olivares, BS, Sergio Gonzalez, BA, Timothy Pfeiffer, BS, Reena Vishwanath, BA, Michael C. Jensen, MD, Steven J. Forman, MD, Laurence J.N. Cooper, MD, PhD

Blood (2004) 104 (11): 1748.

https://doi.org/10.1182/blood.V104.11.1748.1748

Published: 2004

Journal Articles

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effect

Laurence J. N. Cooper, Max S. Topp, Lisa Marie Serrano, Sergio Gonzalez, Wen-Chung Chang, Araceli Naranjo, Christine Wright, Leslie Popplewell, Andrew Raubitschek, Stephen J. Forman, Michael C. Jensen

Blood (2003) 101 (4): 1637–1644.

https://doi.org/10.1182/blood-2002-07-1989

Published: 2003

NARROW

CD28-Costimulation Provided through a CD19-Specific Chimeric Immunoreceptor Enhances In Vivo Persistence and Anti-Tumor Efficacy of Adoptively Transferred T Cells.

Artificial Antigen Presenting Cell Can Be Used To Propagate Genetically Modified CD19-Specific T Cells through Chimeric Antigen Receptor.

Enhanced antilymphoma efficacy of CD19-redirected influenza MP1–specific CTLs by cotransfer of T cells modified to present influenza MP1

Cord Blood-Derived T Cells Can Be Genetically Engineered to Be B-Lineage All-Specific: Towards Adoptive Immunotherapy after Umbilical Cord Blood Transplantation.

T Cells Genetically Modified to Be CD19-Specific with Improved Potential for Trafficking and Activation.

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effect

Email alerts

ASH Publications

American Society of Hematology

CD28-Costimulation Provided through a CD19-Specific Chimeric Immunoreceptor Enhances In Vivo Persistence and Anti-Tumor Efficacy of Adoptively Transferred T Cells.

Artificial Antigen Presenting Cell Can Be Used To Propagate Genetically Modified CD19-Specific T Cells through Chimeric Antigen Receptor.

Enhanced antilymphoma efficacy of CD19-redirected influenza MP1–specific CTLs by cotransfer of T cells modified to present influenza MP1

Cord Blood-Derived T Cells Can Be Genetically Engineered to Be B-Lineage All-Specific: Towards Adoptive Immunotherapy after Umbilical Cord Blood Transplantation.

T Cells Genetically Modified to Be CD19-Specific with Improved Potential for Trafficking and Activation.

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effect

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only